在儿科喘中维持和缓解疗法:最近证据的简要审查-第二部分
Rahaf Alharbi1, Adel S Alharbi2
1Pharmaceutical Services Department, and Department of Pediatrics, Pediatric Sleep Disorders Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Pediatric annals
|March 5, 2026
概括
维护和缓解疗法 (MART) 简化了儿童喘治疗,使用单个吸入器进行日常控制和缓解症状. 这种方法在减少喘恶化和改善喘儿童的坚持方面表现有前途.
科学领域:
- 儿科肺病学 儿科肺病学
- 呼吸系统医学 呼吸系统医学
- 药物治疗 药物治疗
背景情况:
- 儿童喘是一种常见的慢性呼吸道疾病.
- 吸入性皮质类固醇 (ICS) 和长效β-2激动剂 (LABA) 是标准的治疗方法.
- 与单独的吸入器的坚持问题导致了维护和缓解疗法 (MART) 的发展.
研究的目的:
- 审查MART在儿童喘中的合理性和临床疗效.
- 讨论与儿童MART相关的特殊考虑和安全问题.
- 突出了对MART长期影响的进一步研究的需要.
主要方法:
- 关于MART在儿童喘中的最新研究的文献综述.
- 临床试验数据分析,将MART与传统的ICS-LABA疗法进行比较.
- 检查安全数据,包括过度使用和对生长的影响.
主要成果:
- 马特简化了治疗方案,使用单个吸入器进行维护和缓解症状.
- 研究表明,与传统治疗相比,MART可以减少喘恶化,改善喘患者的坚持.
- 潜在的担忧包括长期安全性,过度使用和对增长和发展的影响.
结论:
- 马特提供了一种简化且可能更有效的治疗策略,用于儿童喘.
- 为了充分了解MART在儿童的长期安全性和最佳使用,需要进一步的研究.
- 个性化治疗策略对于有效管理儿科喘至关重要.
相关概念视频
Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma-IV: Nursing Management
4.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
4.0K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
Antiasthma Drugs: Leukotriene Modifiers
2.1K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.1K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K


